期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

替罗非班对老年不稳定型心绞痛的疗效观察 被引量：2

下载PDF
导出
摘要 目的评价老年不稳定型心绞痛患者中应用血小板膜糖蛋白Ⅱb/Ⅲa受体拮抗剂替罗非班的有效性及安全性。方法符合老年不稳定型心绞痛患者69例,根据是否应用替罗非班分为观察组(35例)和对照组(34例)。观察两组患者心绞痛控制疗效,心功能影响,出血并发症,血小板减少情况。结果两组患者心绞痛疗效比较,治疗前后心功能比较,差异均有统计学意义(P<0.05);出血情况及血小板在治疗前后比较,差异无统计学意义(P>0.05)。结论替罗非班在老年不稳定型心绞痛患者治疗中是安全有效的。
作者 王永红 闫长青
机构地区 河北省保定市满城县医院
出处 《中西医结合心脑血管病杂志》 2012年第11期1381-1382,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 不稳定型心绞痛 替罗非班 出血情况 血小板
分类号 R541.4 [医药卫生—心血管疾病] R256.2 [医药卫生—中医内科学]
  • 相关文献

参考文献5

二级参考文献33

  • 1Fragnfin during Instability in Coronary Artery Disease (FRISC) study group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet, 1996,347:561-568.
  • 2Klein W, Buchwald A, Hillis SE, et al. Comparison of low- molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC) . Circulation, 1997,96:61-68.
  • 3Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfraetionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction : FRAX. I.S. ( FRAxiparine in Ischaemic Syndrome). Eur Heart J, 1999,20 : 1553-1562.
  • 4Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low- molecular-weight heparin with unfract/onated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med, 1997,337:447-452.
  • 5Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/ non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) llB trial. Circulation, 1999,100: 1593-1601.
  • 6FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC Ⅱ prospective randomised multicentre study. Lancet, 1999,354:708- 715.
  • 7Wallentin L, Bergstrand L, Dellborg M, et al. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. Eur Heart J, 2003,24:897-908.
  • 8Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med ,2006 ,354 :1477-1488.
  • 9Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med, 2006, 354 : 1464-1476.
  • 10Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction : the OASIS-6 randomized trial. JAMA, 2006,295:1519-1530.

共引文献51

同被引文献12

引证文献2

二级引证文献3

中西医结合心脑血管病杂志
2012年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部